Triptorelin Market Trends

  • Report ID: 5019
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Triptorelin Market Trends

Growth Drivers

  • Growing Prevalence of HIV

According to the World Health Organization, about 38.4 million people worldwide were living with HIV in 2021. Hence, there has been going numerous trials to check the efficiency of triptorelin in HIV patient. However, even though this treatment is not widely used in HIV patients, owing to the ongoing research & development and huge investment from the pharmaceutical organization for the same, triptorelin treatment is estimated to be used to treat such patients during the forecast timeframe.

  • Rise in Prostate Cancer Among Men

The second most frequently diagnosed cancer and the fifth highest cause of cancer death in males globally is considered to be prostate cancer, with a poised 1,414,000 new cancer cases and 375,304 deaths in 2020. The hormone testosterone is required for prostate cancer to develop. The testicles in men produce almost all of the testosterone. Triptorelin inhibits testosterone production in the testicles, lowering testosterone levels and slowing or halting the proliferation of cancer cells.

  • Surge in the Number of Women Suffering from Endometriosis

According to the World Health Organization, globally about 10% or 190 million women or girls of reproductive age are affected by endometriosis. It causes life-impacting pain in women during sexual intercourse, periods, bowel moment, and more. Hence, its treatment is necessary. Therefore, the use of triptorelin is growing since it has been proven effective with an acceptable safety profile. Also, since it has positive results on the reproductive part of the women, the problem in becoming could be diagnosed.

Challenges

  • High Price of Triptorelin Drugs - Despite having a huge client base, the triptorelin market has a significant obstacle which includes expensive triptorelin drug manufacturing costs, which are passed down to consumers as high medical costs. The expense of manufacturing a drug is further boosted by the fact that the raw materials are unique to the drug, making it essential that they be of high quality. Additionally, the product availability is hindered to those who could afford it owing to the intricacy of the triptorelin manufacturing process, which involves a variety of biological or chemical procedures.
  • Side Effects of Triptorelin
  • Lack of Awareness Among People

Triptorelin Market: Key Insights

Base Year

2024

Forecast Year

2025-2037

CAGR

5.4%

Base Year Market Size (2024)

USD 11.1 billion

Forecast Year Market Size (2037)

USD 21.99 billion

Regional Scope

  • North America (U.S., and Canada)
  • Asia Pacific (Japan, China, India, Indonesia, Malaysia, Australia, South Korea, Rest of Asia Pacific)
  • Europe (UK, Germany, France, Italy, Spain, Russia, NORDIC, Rest of Europe)
  • Latin America (Mexico, Argentina, Brazil, Rest of Latin America)
  • Middle East and Africa (Israel, GCC North Africa, South Africa, Rest of the Middle East and Africa)

Get more information on this report: Request Free Sample PDF

Browse Key Market Insights with Data Illustration:


Author Credits:  Radhika Pawar


  • Report ID: 5019
  • Published Date: Dec 20, 2024
  • Report Format: PDF, PPT

Frequently Asked Questions (FAQ)

In the year 2025, the industry size of triptorelin is evaluated at USD 12.08 billion.

The triptorelin market size was over USD 11.1 billion in 2024 and is poised to exceed USD 21.99 billion by 2037, witnessing over 5.4% CAGR during the forecast period i.e., between 2025-2037. The market growth is driven by growing prevalence of HIV, the rise in prostate cancer among people, and the surge in the number of women suffering from endometriosis.

North America industry is predicted to dominate majority revenue share by 2037, backed by growing demand for hormone therapy among men.

The major players in the market are Ipsen Pharma, Bachem, Chengdu Tiantaishan pharmaceutical, Ferring Pharmaceuticals, Tecnofarma SA, Dr. Reddy's Laboratories Ltd, Arbor Pharmaceutical, Inc., Teva Pharmaceutical Industries Ltd., Debiopharm International SA, Verity Pharmaceuticals Inc.
Inquiry Before Buying Request Free Sample
logo
  GET A FREE SAMPLE

FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.

 Request Free Sample Copy

Have questions before ordering this report?

Inquiry Before Buying
Inquiry Before Buying Request Free Sample